Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9180)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2016 (publication date) through Dec 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Facciorusso A, Serviddio G, Muscatiello N. Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis. World J Hepatol 2016; 8(18): 770-778 [PMID: 27366304 DOI: 10.4254/wjh.v8.i18.770] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i18/770.htm |
| Number | Citing Articles |
| 1 |
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. WIREs Nanomedicine and Nanobiotechnology 2022; 14(2) doi: 10.1002/wnan.1749
|
| 2 |
Nicolas Voizard, Milena Cerny, Anis Assad, Jean-Sébastien Billiard, Damien Olivié, Pierre Perreault, Ania Kielar, Richard K. G. Do, Takeshi Yokoo, Claude B. Sirlin, An Tang. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights into Imaging 2019; 10(1) doi: 10.1186/s13244-019-0801-z
|
| 3 |
Mian Khalid, Alisa Likhitsup, Neehar D. Parikh. Embolic and Ablative Therapy for Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 87 doi: 10.1016/j.cld.2024.08.003
|
| 4 |
Michael Hsu, Muneeb Ahmed, Ammar Sarwar. Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular Carcinoma. Current Hepatology Reports 2018; 17(4): 399 doi: 10.1007/s11901-018-0428-4
|
| 5 |
Andrea Chierici, Andrew Ofosu, Ivan Cincione, Rodolfo Sacco, Christian Cotsoglou, Antonio Facciorusso. Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 205 doi: 10.1016/j.hbpd.2020.12.005
|
| 6 |
Yuna Kim, Han Ah Lee, Jae Seung Lee, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soon Ho Um, Yeon Seok Seo, Seung Up Kim. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma. Cancer Investigation 2021; 39(3): 274 doi: 10.1080/07357907.2020.1870126
|
| 7 |
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68(2): 723 doi: 10.1002/hep.29913
|
| 8 |
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology. 2020; : 81 doi: 10.1007/978-3-030-48767-6_6
|
| 9 |
Antonio Facciorusso, Mohamed A. Abd El Aziz, Rodolfo Sacco. Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis. Cancers 2019; 12(1): 36 doi: 10.3390/cancers12010036
|
| 10 |
Guangsheng Zhao, Song Liu, Songbai Chen, Zhizhong Ren, Chuang Li, Jie Bian, Jianlin Wu, Jun Zhou, Yuewei Zhang. Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Delivery 2021; 28(1): 1356 doi: 10.1080/10717544.2021.1943057
|
| 11 |
Ji Kim, Hee-Chul Nam, Chang-Wook Kim, Hee Cho, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Hyun Yang, Si Bae, Suho Kim, Jung Oh, Ho Chun, Chang Jeon, Jaegyoon Ahn, Pil Sung. Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study. Cancers 2023; 15(17): 4233 doi: 10.3390/cancers15174233
|
| 12 |
Luca Filippi, Giovan Giuseppe Di Costanzo, Raffaella Tortora, Giuseppe Pelle, Roberto Cianni, Orazio Schillaci, Oreste Bagni. Repeated Treatment with 90Y-Microspheres in Intrahepatic Cholangiocarcinoma Relapsed After the First Radioembolization. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(4): 231 doi: 10.1089/cbr.2018.2718
|
| 13 |
Dong Ik Cha, Min Woo Lee, Dongho Hyun, Soo Hyun Ahn, Woo Kyoung Jeong, Hyunchul Rhim. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes. Cancers 2023; 15(21): 5193 doi: 10.3390/cancers15215193
|
| 14 |
Saad Alghamdi, Waleed Al-Hamoudi. Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology. Cancers 2023; 15(21): 5115 doi: 10.3390/cancers15215115
|
| 15 |
Antonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Saurabh Chandan, Antonio Ambrosi, Irene Bargellini, Matteo Renzulli, Rodolfo Sacco. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis. Digestive and Liver Disease 2022; 54(3): 316 doi: 10.1016/j.dld.2021.06.003
|
| 16 |
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma. Cancers 2023; 15(13): 3347 doi: 10.3390/cancers15133347
|
| 17 |
Daan Andel, Lotte van den Bent, Marnix Gerard Ernest Hendrik Lam, Maarten Leonard Johannes Smits, Isaac Quintus Molenaar, Joep de Bruijne, Miangela Marie Laclé, Onno Kranenburg, Inne Hildbrand Max Borel Rinkes, Jeroen Hagendoorn. 90Y-/166Ho- ‘Radiation lobectomy’ for liver tumors induces abnormal morphology and impaired drainage of peritumor lymphatics. JHEP Reports 2024; 6(2): 100981 doi: 10.1016/j.jhepr.2023.100981
|
| 18 |
Cristina Mosconi, Rita Golfieri. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; : 319 doi: 10.1007/978-3-030-39021-1_14
|
| 19 |
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2019; 20(7): 1042 doi: 10.3348/kjr.2019.0140
|
| 20 |
Andrea T. Fisher, Ashley L. Titan, Deshka S. Foster, Patrick J. Worth, George A. Poultsides, Brendan C. Visser, Monica M. Dua, Jeffrey A. Norton. Management of Ileal Neuroendocrine Tumors with Liver Metastases. Journal of Gastrointestinal Surgery 2020; 24(7): 1530 doi: 10.1007/s11605-019-04309-7
|
| 21 |
Andreas G. Zori, Media N. Ismael, Alpna R. Limaye, Roberto Firpi, Giuseppe Morelli, Consuelo Soldevila-Pico, Amitabh Suman, Jeffrey D. Vogel, Michael Lazarowicz, Brian S. Geller, Beau Toskich, David H. Gonzalo, Mark W. Johnson, Roniel Cabrera. Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation. American Journal of Clinical Oncology 2020; 43(5): 325 doi: 10.1097/COC.0000000000000678
|
| 22 |
Matteo Renzulli, Nicolò Brandi, Giulia Argalia, Stefano Brocchi, Andrea Farolfi, Stefano Fanti, Rita Golfieri. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions. La radiologia medica 2022; 127(2): 129 doi: 10.1007/s11547-022-01449-w
|
| 23 |
David M. Liu, Thomas WT. Leung, Pierce KH. Chow, David CE. Ng, Rheun-Chuan Lee, Yun Hwan Kim, Yilei Mao, Yu-Fan Cheng, Gao-Jun Teng, Wan Yee Lau. Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia. International Journal of Surgery 2022; 102: 106094 doi: 10.1016/j.ijsu.2021.106094
|
| 24 |
Osman Ahmed, Anjana Pillai. Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy. American Journal of Gastroenterology 2020; 115(11): 1733 doi: 10.14309/ajg.0000000000000931
|
| 25 |
Tim Bomberna, Saar Vermijs, Maryse Lejoly, Chris Verslype, Lawrence Bonne, Geert Maleux, Charlotte Debbaut. A Hybrid Particle-Flow CFD Modeling Approach in Truncated Hepatic Arterial Trees for Liver Radioembolization: A Patient-specific Case Study. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.914979
|
| 26 |
Juan C. Mejia, Jennifer Pasko. Primary Liver Cancers. Surgical Clinics of North America 2020; 100(3): 535 doi: 10.1016/j.suc.2020.02.013
|
| 27 |
Mignote Yilma, Richie Houhong Xu, Varun Saxena, Monica Muzzin, Lue-Yen Tucker, Jeffrey Lee, Neil Mehta, Nizar Mukhtar. Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System. JAMA Network Open 2024; 7(9): e2435066 doi: 10.1001/jamanetworkopen.2024.35066
|
| 28 |
Omar Abdel-Rahman, Zeinab Elsayed. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD011313.pub3
|
| 29 |
Nguyen Van Thai, Nguyen Tien Thinh, Thai Doan Ky, Mai Hong Bang, Dinh Truong Giang, Le Ngoc Ha, Mai Hong Son, Dao Duc Tien, Hyun Woong Lee. Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01805-6
|
| 30 |
Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li, Quqin Lu. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07692-6
|
| 31 |
Simon Lemieux, Alex Buies, Alexis F. Turgeon, Julie Hallet, Gaétan Daigle, François Côté, Steeve Provencher, Yi-Hsiang Huang. Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 2021; 16(3): e0247958 doi: 10.1371/journal.pone.0247958
|
| 32 |
Chang-Yi Lu, Chih-Yang Hsiao, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Hung-Ju Su, Kai-Wen Huang. DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma. Cancers 2023; 15(18): 4465 doi: 10.3390/cancers15184465
|
| 33 |
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies. Oncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
|
| 34 |
Clayton Li, Ryan Hickey, Robert J. Lewandowski, Riad Salem. IR Playbook. 2024; : 475 doi: 10.1007/978-3-031-52546-9_39
|
| 35 |
Aaron Coleman, Elainea N. Smith, Samuel J. Galgano, Kristin K. Porter. Oncologic Imaging : a Multidisciplinary Approach. 2023; : 109 doi: 10.1016/B978-0-323-69538-1.00010-0
|
| 36 |
Antonio Facciorusso. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World Journal of Gastroenterology 2018; 24(2): 161-169 doi: 10.3748/wjg.v24.i2.161
|
| 37 |
Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression. Cancer Management and Research 2021; : 4013 doi: 10.2147/CMAR.S304591
|
| 38 |
Cristina Mosconi, Alberta Cappelli, Cinzia Pettinato, Maria Adriana Cocozza, Giulio Vara, Eleonora Terzi, Maria Cristina Morelli, Elisa Lodi Rizzini, Matteo Renzulli, Francesco Modestino, Matteo Serenari, Rachele Bonfiglioli, Letizia Calderoni, Elena Tabacchi, Matteo Cescon, Alessio Giuseppe Morganti, Franco Trevisani, Fabio Piscaglia, Stefano Fanti, Lidia Strigari, Alessandro Cucchetti, Rita Golfieri. Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value. Journal of Clinical Medicine 2022; 11(24): 7469 doi: 10.3390/jcm11247469
|
| 39 |
Cathal O’Leary, Mary Mahler, Michael C. Soulen. Curative-Intent Therapies in Localized Hepatocellular Carcinoma. Current Treatment Options in Oncology 2020; 21(4) doi: 10.1007/s11864-020-0725-3
|
| 40 |
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
|
| 41 |
Kelley Coffman-D’Annibale, Changqing Xie, Donna M Hrones, Shadin Ghabra, Tim F Greten, Cecilia Monge. The current landscape of therapies for hepatocellular carcinoma. Carcinogenesis 2023; 44(7): 537 doi: 10.1093/carcin/bgad052
|
| 42 |
Franziska Galiè, K. J. Paprottka, M. Ingrisch, A. Todica, H. Ilhan, M. Michl, T. Geith, M. Fabritius, E. De Toni, P. M. Paprottka. Impact of Baseline Cholinesterase in Patients with Primary Liver Tumors Undergoing Radioembolization: Impact on Outcome. SN Comprehensive Clinical Medicine 2019; 1(2): 85 doi: 10.1007/s42399-018-0029-0
|
| 43 |
Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Ji Hoon Kim, Ahlim Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Dong Jae Shim, Doyoung Kim, Myungsoo Kim. A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Cancers 2023; 15(17): 4423 doi: 10.3390/cancers15174423
|
| 44 |
Chun Zhao, Hongyan Dai, Juwei Shao, Qian He, Wei Su, Peng Wang, Qiuyue Tang, Junren Zeng, Song Xu, Juanjuan Zhao, Shutian Xiang. Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.680691
|
| 45 |
Antonio Facciorusso, Irene Bargellini, Marina Cela, Ivan Cincione, Rodolfo Sacco. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2020; 12(4): 897 doi: 10.3390/cancers12040897
|
| 46 |
Irene Perez, Fabian J Bolte, William Bigelow, Zachary Dickson, Neeral L Shah. Step by Step: Managing the Complications of Cirrhosis. Hepatic Medicine: Evidence and Research 2021; : 45 doi: 10.2147/HMER.S278032
|
| 47 |
Matthias Jeschke, Johannes M. Ludwig, Catherine Leyh, Kim M. Pabst, Manuel Weber, Jens M. Theysohn, Christian M. Lange, Ken Herrmann, Hartmut H. -J. Schmidt, Leonie S. Jochheim. Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab. Cancers 2023; 15(17): 4274 doi: 10.3390/cancers15174274
|
| 48 |
KLCA Korean Liver Cancer Association, NCC National Cancer Center. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 2019; 13(3): 227 doi: 10.5009/gnl19024
|
| 49 |
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage. European Journal of Nuclear Medicine and Molecular Imaging 2019; 46(3): 661 doi: 10.1007/s00259-018-4152-7
|
| 50 |
Yanyan Cao, Tao Sun, Xiaopeng Guo, Tao Ouyang, Xuefeng Kan, Lei Chen, Bin Liang, Mingfu Wang, Chuansheng Zheng. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.673378
|
| 51 |
Bingnan Zhang, Richard S. Finn. Resistance to Molecular Therapies for Hepatocellular Carcinoma. Resistance to Targeted Anti-Cancer Therapeutics 2017; 13: 133 doi: 10.1007/978-3-319-56197-4_8
|